Prospective Longitudinal Multicentric Study to Evaluate Syde® Digital Endpoints in Healthy Adults

NCT ID: NCT06679608

Last Updated: 2026-01-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

129 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-01-20

Study Completion Date

2027-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study aims to constitute a longitudinal Syde® digital health technology (DHT) dataset to serve as a healthy adult reference for Syde® digital variables development and validation. Subjects will be assessed every 6 months for 2 years.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Adults

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male or female aged between 18 and 65 years old
* Signed informed consent
* Subjects with a reported BMI ≥ 17 and ≤ 35
* Subject with unlimited internet connection at home and authorizing automatic data upload
* Subject willing and able to comply with all study procedures including:

* baseline data and questionnaires data entry on EDC (electronic data capture) throughout the study
* Syde® related procedures
* Subject confirming to be affiliated to, or beneficiary from, a social security category

Exclusion Criteria

* Elite athletes (at a national level)
* Pregnant women
* Presence of an orthopedic, neuromuscular, or neurological pathology affecting walking gait quality or requiring a walking aid
* Subjects reporting to have an incapacity or invalidity or to be affected by a chronic disease which can affect their activity and/or their lower limb function
* Subjects reporting to have undergone recent surgical procedures, trauma (within 6 months), or affected by a disease or condition affecting lower limb function within 3 weeks before their inclusion
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

SYSNAV

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Shotaro Tachibana

Role: PRINCIPAL_INVESTIGATOR

Hospices Civils de Lyon - Hôpital Femme Mère Enfant (HFME)

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospices Civils de Lyon - Hôpital Femme Mère Enfant (HFME)

Bron, , France

Site Status

Hôpital NOVO (Nord-Ouest Val d'Oise)

Pontoise, , France

Site Status

CHU ROUEN - Hôpital Charles Nicolle

Rouen, , France

Site Status

SYSNAV

Vernon, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024-A01925-42

Identifier Type: OTHER

Identifier Source: secondary_id

PR5030-72

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.